Prosecution Insights
Last updated: April 19, 2026

Examiner: LOUNTOS, GEORGE THEMISTOCLIS

Tech Center 1600 • Art Units: 1652

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
14
Total Applications
+0.0%
Interview Lift
1175
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

2.9%
§101 Eligibility
30.0%
§102 Novelty
25.7%
§103 Obviousness
34.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18523363 COMPOSITION FOR IMPROVING, PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING NAMPT-DERIVED PEPTIDE AS ACTIVE INGREDIENT Non-Final OA Industry-University Cooperation Foundation Hanyang University ERICA Campus
18286067 A Genus of Corynebacterium Microorganism for Producing L-Arginine and a Method for Producing L-Arginine Using the Same Non-Final OA CJ CHEILJEDANG CORPORATION
18466660 METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF 4-VINYLPHENOL Non-Final OA NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
17767425 MONO-HYDROXY OR DI-HYDROXY DERIVATIVES OF POLYUNSATURATED FATTY ACIDS, PRODUCTION METHOD THEREFOR, AND USE THEREOF Non-Final OA KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
18519569 FOOD AND DRUG COMPOSITION CONTAINING NOVEL ALDEHYDE DEHYDROGENASE FOR SUPPRESSING TREMOR OR MOVEMENT DISORDER Non-Final OA PICOENTECH Co., LTD.
18285005 CELL CULTURE PROCESS FOR FUSION PROTEIN COMPOSITION Non-Final OA DR. REDDY’S LABORATORIES LIMITED
18085637 INSTANT NUCLEIC ACID TEST METHOD AND TEST KIT FOR PATHOGENIC MUTANTS Non-Final OA Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
17719015 High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier Non-Final OA University of Rhode Island Board of Trustees
17702719 TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO Non-Final OA Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS)

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month